MXPA06000796A - Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones. - Google Patents

Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones.

Info

Publication number
MXPA06000796A
MXPA06000796A MXPA06000796A MXPA06000796A MXPA06000796A MX PA06000796 A MXPA06000796 A MX PA06000796A MX PA06000796 A MXPA06000796 A MX PA06000796A MX PA06000796 A MXPA06000796 A MX PA06000796A MX PA06000796 A MXPA06000796 A MX PA06000796A
Authority
MX
Mexico
Prior art keywords
diazabicyclo
human patients
prophylaxis
male human
treatment
Prior art date
Application number
MXPA06000796A
Other languages
English (en)
Spanish (es)
Inventor
Werner Cautreels
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of MXPA06000796A publication Critical patent/MXPA06000796A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MXPA06000796A 2003-07-21 2004-07-19 Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones. MXPA06000796A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102243 2003-07-21
PCT/EP2004/051532 WO2005011690A1 (fr) 2003-07-21 2004-07-19 Utilisation de composes de 3,7-diazabicyclo[3,3,1]nonane pour traiter et/ou prevenir des evenements arythmiques chez des patients humains males

Publications (1)

Publication Number Publication Date
MXPA06000796A true MXPA06000796A (es) 2006-04-07

Family

ID=34112472

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06000796A MXPA06000796A (es) 2003-07-21 2004-07-19 Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones.

Country Status (8)

Country Link
EP (1) EP1648456A1 (fr)
JP (1) JP2006528155A (fr)
CN (1) CN1822833A (fr)
AU (1) AU2004260624A1 (fr)
BR (1) BRPI0412247A (fr)
CA (1) CA2533492A1 (fr)
MX (1) MXPA06000796A (fr)
WO (1) WO2005011690A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012154760A1 (fr) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Composés hétérocycliques condensés utilisés comme modulateurs des canaux sodiques
TWI549944B (zh) 2011-07-01 2016-09-21 吉李德科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (fr) 2011-07-01 2018-04-28
WO2014134419A1 (fr) * 2013-03-01 2014-09-04 Gilead Sciences, Inc. Utilisation de bloqueurs ikach pour le traitement de maladies cardiaques

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3234697A1 (de) * 1982-09-18 1984-03-22 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue diazabicyclo-(3,3,1)-nonane
PT88381B (pt) * 1987-09-09 1995-07-06 Kali Chemie Pharma Gmbh Processo para a preparacao de novos compostos 3,7-diazabiciclo{3,3,1} nonano, e de composicoes farmaceuticas que contem estes compostos
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
TW200418468A (en) * 2002-11-18 2004-10-01 Solvay Pharm Gmbh Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1]nonane compounds and method of treatments relating to anti-arrhytmic events

Also Published As

Publication number Publication date
JP2006528155A (ja) 2006-12-14
BRPI0412247A (pt) 2006-09-19
CA2533492A1 (fr) 2005-02-10
AU2004260624A1 (en) 2005-02-10
CN1822833A (zh) 2006-08-23
WO2005011690A1 (fr) 2005-02-10
EP1648456A1 (fr) 2006-04-26

Similar Documents

Publication Publication Date Title
HUP0301452A2 (hu) Fotokemoterápiás szert és mukoadhéziós szert tartalmazó gyógyszerkészítmény és alkalmazása
TWI256950B (en) Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them
CA2403687A1 (fr) Articles chirurgicaux
EE04854B1 (et) Oksabispidiinühendid, nende valmistamise meetod ning ravimvorm kasutamiseks südame arütmia raviks ja profülaktikaks
MY138341A (en) Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use
HUP0000057A2 (hu) Fotokemoterápiás készítmények
CA2321560A1 (fr) Traitement de la retinopathie diabetique ou des inflammations oculaires au moyen d'un inhibiteur des tyrosine-kinases tel que la genisteine
WO2002088100A3 (fr) 3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes
CA2143610A1 (fr) Utilisation de norastemizole pour le traitement de troubles allergiques
AU2108500A (en) Galenic formulation containing biotin
CA2274686A1 (fr) Composes a base d'acide sulfonique ou de sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide
HUP0400553A2 (hu) Gyógyászati készítmények
EE200300504A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
IL179859A0 (en) Oral sustained release formulation of tedisamil with gastric retention properties
NO20053010L (no) Flytende farmasoytiske preparater inneholdende 3,7- diazabisyklo [3,3,1] nonaner for behandling av anti- arytmiske hendelser.
MXPA06000796A (es) Uso de los compuestos 3,7-diazabiciclo [3,3,1]nonano para el tratamiento y/o profilaxis de eventos antiarritmicos en pacientes humanos varones.
HUP0302288A2 (hu) Kardiális aritmiák kezelésében alkalmazható oxa-biszpidin-származék és az ezt tartalmazó gyógyszerkészítmények
PL330768A1 (en) Perpetration for use in therapy and prophylactics of dermatological diseases
MXPA03003980A (es) Uso de melagatran para la elaboracion de un medicamento para el tratamiento de transtornos isquemicos.
EE200300495A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
EE200300506A (et) 3,7-diasabitsüklo[3.3.1]preparaadid, nende valmistamise meetod ja nimetatud preparaatide kasutaminesüdame arütmiate profülaktikas või ravis
WO2003001877A3 (fr) Diagnostic et traitement des rejets de tissu cardiaque
WO2002051404A8 (fr) Compositions orales
Bayley Long-term ventricular pacing in treatment of sinoatrial block
HUP0303075A2 (hu) Az 5HT4 receptor antagonisták használata bizonyos kardiovaszkuláris állapotok megelőzésében vagy kezelésében és az erre alkalmas gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
FA Abandonment or withdrawal